• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视觉电诊断在1型神经纤维瘤病患儿管理中的作用

The role of visual electrodiagnostics in management of children with neurofibromatosis type 1.

作者信息

Tekavčič Pompe Manca, Pečarič Meglič Nuška, Šuštar Habjan Maja

机构信息

University Eye Clinic Ljubljana, University Medical Centre Ljubljana, Grablovičeva 46, 1000, Ljubljana, Slovenia.

Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.

出版信息

Doc Ophthalmol. 2023 Apr;146(2):121-136. doi: 10.1007/s10633-023-09920-3. Epub 2023 Jan 18.

DOI:10.1007/s10633-023-09920-3
PMID:36652041
Abstract

PURPOSE

To evaluate the role of visual electrodiagnostic testing in children with neurofibromatosis type 1 (NF1) despite improved accessibility to magnetic resonance imaging (MRI).

METHODS

The records from 39 children (78 eyes, 15 boys, 24 girls, average age at last visit of 11.5 ± 4.3 years, average follow-up time of 7.8 ± 3.9 years) with genetically confirmed NF1 were retrospectively analysed. They all underwent a thorough ophthalmological investigation, including age-appropriate visual acuity testing, anterior segment evaluation for Lisch nodules and a dilated fundus examination. If children were cooperative enough, colour vision was tested using the Hardy-Rand-Rittler test, visual fields were evaluated with Goldmann perimetry. All performed MRI of the brain and orbits as part of the standard of care protocol. Visual electrodiagnostics included electroretinography (ERG) and visual evoked potentials (VEP) using a standard protocol in older children, whereas with less cooperative children a modified protocol according to the Great Ormond Street Hospital (GOSH protocol) was used.

RESULTS

The average visual acuity was 0.8 ± 0.3, colour vision was abnormal in 6%, perimetry in 8%, Lisch nodules were present in 62%, and the optic disc was pale in 66% of all eyes. Plexiform neurofibroma of the eyelid/orbit was present in 4%. Optic pathway glioma (OPG) was detected with MRI in 22 (57%) and in 6/22 treatment was indicated. Other intracranial NF1-related lesions were documented in 70% of children. VEP were abnormal in 16/39 of all children with NF1 (41%) comprising 14/22 (65%) of children with confirmed OPG and 2/17 (12%) of children without OPG. All full-field and pattern ERG responses were within normal limits. All individual VEP results are described and three cases from this cohort of children are presented in detail to illustrate the importance of VEP testing. In Case 1, VEP abnormality suggested subsequent MRI of the brain under general anaesthesia, which was otherwise contraindicated according to normal clinical findings and his young age. In Cases 2 and 3, VEP provided more precise functional information during the follow-up of OPG, while other psychophysical tests remained unchanged.

CONCLUSIONS

Electrodiagnostics has multifactorial role and importance in children with NF1, either when visual pathway function is impaired in young children, even before MRI under general anaesthesia and other psychophysical tests can be performed, as well as for a more precise monitoring of the visual pathway function before potential treatment of OPG, or after it, to evaluate its success.

摘要

目的

尽管磁共振成像(MRI)的可及性有所提高,但仍要评估视觉电诊断测试在1型神经纤维瘤病(NF1)儿童中的作用。

方法

对39例经基因确诊为NF1的儿童(78只眼,15名男孩,24名女孩,末次就诊时平均年龄为11.5±4.3岁,平均随访时间为7.8±3.9年)的记录进行回顾性分析。他们均接受了全面的眼科检查,包括适合年龄的视力测试、针对Lisch结节的眼前节评估以及散瞳眼底检查。如果儿童配合度足够,则使用Hardy-Rand-Rittler测试进行色觉测试,用Goldmann视野计评估视野。所有患儿均按照标准护理方案进行了脑部和眼眶的MRI检查。视觉电诊断包括对年龄较大儿童使用标准方案进行视网膜电图(ERG)和视觉诱发电位(VEP)检查,而对于配合度较低的儿童,则使用根据大奥蒙德街医院(GOSH方案)修改的方案。

结果

平均视力为0.8±0.3,6%的患儿色觉异常,8%的患儿视野异常,62%的眼睛存在Lisch结节,66%的眼睛视盘苍白。4%的患儿存在眼睑/眼眶的丛状神经纤维瘤。MRI检测出22例(57%)患有视路胶质瘤(OPG),其中6/22例需要进行治疗。70%的儿童记录有其他颅内NF1相关病变。在所有NF1患儿中,16/39例(41%)VEP异常,其中确诊OPG的患儿中有14/22例(65%),未患OPG的患儿中有2/17例(12%)。所有全视野和图形ERG反应均在正常范围内。描述了所有个体的VEP结果,并详细介绍了该队列中的3例患儿,以说明VEP测试的重要性。在病例1中,VEP异常提示随后在全身麻醉下进行脑部MRI检查,否则根据正常临床检查结果及患儿年龄,该项检查是禁忌的。在病例2和病例3中,VEP在OPG随访期间提供了更精确的功能信息,而其他心理物理学测试结果保持不变。

结论

电诊断在NF1儿童中具有多方面的作用和重要性,无论是在幼儿视觉通路功能受损时,甚至在可以进行全身麻醉下的MRI检查和其他心理物理学测试之前,还是在OPG可能接受治疗之前或之后,用于更精确地监测视觉通路功能以评估治疗效果。

相似文献

1
The role of visual electrodiagnostics in management of children with neurofibromatosis type 1.视觉电诊断在1型神经纤维瘤病患儿管理中的作用
Doc Ophthalmol. 2023 Apr;146(2):121-136. doi: 10.1007/s10633-023-09920-3. Epub 2023 Jan 18.
2
Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature.1型神经纤维瘤病患者的视路胶质瘤与脑局灶性异常信号强度:134例患者的特征、治疗选择及随访并文献简要回顾
Anticancer Res. 2016 Aug;36(8):4095-121.
3
Can screening for optic nerve gliomas in patients with neurofibromatosis type I be performed with visual-evoked potential testing?对于I型神经纤维瘤病患者,能否通过视觉诱发电位测试来筛查视神经胶质瘤?
J AAPOS. 2006 Aug;10(4):307-11. doi: 10.1016/j.jaapos.2006.02.004.
4
Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients.1型神经纤维瘤病患者的视路胶质瘤:44例患者的随访
J AAPOS. 2010 Apr;14(2):155-8. doi: 10.1016/j.jaapos.2009.11.020.
5
[Prognostic factors of neurofibromatosis type 1-associated optic pathway gliomas in children].[儿童1型神经纤维瘤病相关视路胶质瘤的预后因素]
J Fr Ophtalmol. 2022 Feb;45(2):173-184. doi: 10.1016/j.jfo.2021.08.012. Epub 2021 Dec 28.
6
Systematic MRI in NF1 children under six years of age for the diagnosis of optic pathway gliomas. Study and outcome of a French cohort.对6岁以下神经纤维瘤病1型(NF1)儿童进行系统性磁共振成像(MRI)以诊断视路胶质瘤。法国队列研究及结果
Eur J Paediatr Neurol. 2016 Mar;20(2):275-281. doi: 10.1016/j.ejpn.2015.12.002. Epub 2015 Dec 17.
7
Comparison of pattern visual-evoked potentials to perimetry in the detection of visual loss in children with optic pathway gliomas.在检测视神经通路胶质瘤患儿视力丧失方面,图形视觉诱发电位与视野检查的比较。
J AAPOS. 2006 Aug;10(4):298-306. doi: 10.1016/j.jaapos.2006.02.003.
8
Visual function assessed by visually evoked potentials in optic pathway low-grade gliomas with and without neurofibromatosis type 1.通过视觉诱发电位评估伴有和不伴有1型神经纤维瘤病的视神经通路低度胶质瘤的视觉功能。
Doc Ophthalmol. 2018 Jun;136(3):177-189. doi: 10.1007/s10633-018-9635-0. Epub 2018 May 15.
9
Optic pathway glioma and the sex association in neurofibromatosis type 1: a single-center study.1 型神经纤维瘤病中的视神经胶质瘤与性别关联:一项单中心研究。
Orphanet J Rare Dis. 2021 Nov 22;16(1):489. doi: 10.1186/s13023-021-02121-8.
10
Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program.一组患有1型神经纤维瘤病和视路胶质瘤的儿童在小儿神经肿瘤学项目随访后的视觉预后。
Neuro Oncol. 2007 Oct;9(4):430-7. doi: 10.1215/15228517-2007-031. Epub 2007 Aug 17.

引用本文的文献

1
Analysis of visual evoked potentials in patients with neurofibromatosis type 1: new concepts.1型神经纤维瘤病患者视觉诱发电位分析:新概念
Front Neurol. 2024 Jul 22;15:1410101. doi: 10.3389/fneur.2024.1410101. eCollection 2024.

本文引用的文献

1
Clinical assessment, investigation, diagnosis and initial management of cerebral visual impairment: a consensus practice guide.临床评估、检查、诊断和脑视觉损伤的初步管理:共识实践指南。
Eye (Lond). 2023 Jul;37(10):1958-1965. doi: 10.1038/s41433-022-02261-6. Epub 2022 Oct 18.
2
An alternative electroretinography protocol for children: a study of diagnostic agreement and accuracy relative to ISCEV standard electroretinograms.一种适用于儿童的视网膜电图替代方案:关于与国际临床视觉电生理学会(ISCEV)标准视网膜电图的诊断一致性和准确性的研究。
Acta Ophthalmol. 2022 May;100(3):322-330. doi: 10.1111/aos.14938. Epub 2021 Jun 14.
3
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation.
修订的 1 型神经纤维瘤病和莱格氏综合征的诊断标准:国际共识建议。
Genet Med. 2021 Aug;23(8):1506-1513. doi: 10.1038/s41436-021-01170-5. Epub 2021 May 19.
4
Neurofibromatosis Type 1-Associated Optic Pathway Glioma in Children: A Follow-Up of 10 Years or More.儿童 1 型神经纤维瘤病相关视神经胶质瘤:10 年以上的随访。
Am J Ophthalmol. 2021 Jan;221:91-96. doi: 10.1016/j.ajo.2020.03.053. Epub 2020 Apr 10.
5
Role of visual evoked potentials and optical coherence tomography in the screening for optic pathway gliomas in patients with neurofibromatosis type I.I 型神经纤维瘤病患者视神经胶质瘤筛查中视觉诱发电位和光学相干断层扫描的作用。
Eur J Ophthalmol. 2021 Mar;31(2):698-703. doi: 10.1177/1120672120906989. Epub 2020 Feb 18.
6
Optic Pathway Gliomas in Neurofibromatosis Type 1.1型神经纤维瘤病中的视路胶质瘤
J Child Neurol. 2018 Jan;33(1):73-81. doi: 10.1177/0883073817739509.
7
Optic Pathway Gliomas in Neurofibromatosis Type 1: An Update: Surveillance, Treatment Indications, and Biomarkers of Vision.1型神经纤维瘤病中的视路胶质瘤:最新进展:监测、治疗指征及视力生物标志物
J Neuroophthalmol. 2017 Sep;37 Suppl 1(Suppl 1):S23-S32. doi: 10.1097/WNO.0000000000000550.
8
ISCEV standard for clinical visual evoked potentials: (2016 update).临床视觉诱发电位的国际临床神经电生理学会(ISCEV)标准:(2016年更新版)
Doc Ophthalmol. 2016 Aug;133(1):1-9. doi: 10.1007/s10633-016-9553-y. Epub 2016 Jul 21.
9
Neurofibromatosis type 1: a multidisciplinary approach to care.神经纤维瘤病 1 型:多学科护理方法。
Lancet Neurol. 2014 Aug;13(8):834-43. doi: 10.1016/S1474-4422(14)70063-8.
10
ISCEV standard for clinical pattern electroretinography (PERG): 2012 update.国际临床视觉电生理学会(ISCEV)临床图形视网膜电图(PERG)标准:2012年更新版
Doc Ophthalmol. 2013 Feb;126(1):1-7. doi: 10.1007/s10633-012-9353-y. Epub 2012 Oct 17.